CAHILL BRIAN JOSEPH (Chief Financial Officer) received a stock award from EAGLE PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/2/2023ACC: 0001209191-23-014650
Officer· Chief Financial Officer
Since Oct 2020
+17.78K
Net shares
Net buyer
$20.1K
Total sold
0
Open market trades
0B · 0S
2
Total transactions
18.50K acquired · 718.00 disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−718.00
Price / share
$28.00
Trade value
$20.10K
% of position
2.4%
2/28/2023
30.09K→29.37K
Common Stock
Direct
Shares
+18.50K
Price / share
—
Trade value
—
% of position
63.0%
3/1/2023
29.37K→47.87K
Total
Net shares
+17.78K
Net value
-$20.10K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/28/2023 | F · Tax Withholding | −718.00 | $28.00 | $20.10K | 2.4% | 30.09K | 29.37K |
| Common Stock Direct | 3/1/2023 | A · Award | +18.50K | — | — | 63.0% | 29.37K | 47.87K |
| Total | +17.78K | -$20.10K | ||||||
Derivative Transactions0
No derivative transactions reported